Akira Nakao

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Sankyo Company, Limited, Sunstar Kabushiki Kaisha. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Nakao. Retrieved from https://idiyas.com/inventor/akira-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 58.3

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 53(Granted Patents)

Location History:

Takatsuki, JP (2002)
Osaka, JP (2007 - 2013)
Tokyo, JP (1999 - 2021)

Company Filing History:

4 out of 462

Daiichi Sankyo Company, Limited

patents

4 out of 613

Sankyo Company, Limited

patents

2 out of 35

Sunstar Kabushiki Kaisha

patents

4. 1 out of 73

Mitsubishi Pharma Corporation

patents

5. 1 out of 263

Mitsubishi Tanabe Pharma Corporation

patents

Years Active: 1999-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10954219 - 1,3-benzodioxole derivative (2021-03-23),

2. 10017500 - 1,3-benzodioxole derivative (2018-07-10),

3. 8513235 - Homocysteine synthase inhibitor (2013-08-20),

4. 8183272 - Indanyl compounds (2012-05-22),

5. 8173631 - Cyclic amine compounds (2012-05-08),

6. 7300645 - Oral composition comprising isomalt and remineralizing enhancing agent (2007-11-27),

7. 7166617 - Cyclic amide derivatives (2007-01-23),

8. RE39420 - 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses (2006-12-04),

9. 7122666 - Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses (2006-10-17),

10. 7091352 - Compounds substituted with bicyclic amino groups (2006-08-15),

11. 6471946 - Oral composition (2002-10-29),

12. 5908858 - 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic (1999-06-01),

Title: The Innovative Legacy of Akira Nakao

Introduction

Akira Nakao, an esteemed inventor based in Tokyo, Japan, has made significant contributions to the field of chemical compounds. With a remarkable portfolio that includes nine patents, Nakao's work focuses primarily on compounds with potential pharmacological applications, particularly in the area of enzyme inhibition.

Latest Patents

Among Nakao's latest inventions is a notable patent for a 1,3-benzodioxole derivative. This innovative compound possesses a specific chemical structure that demonstrates an excellent inhibitory effect on the activities of EZH1 and/or EZH2. The patent outlines this compound, including a pharmacologically acceptable salt, and describes its potential inclusion in pharmaceutical compositions.

Career Highlights

Throughout his career, Akira Nakao has been affiliated with prominent companies in the pharmaceutical industry, notably Sankyo Company, Limited, and Daiichi Sankyo Company, Limited. His extensive experience in these organizations has allowed him to develop and refine his innovative ideas, leading to his notable patent achievements.

Collaborations

Nakao's journey is also marked by valuable collaborations with talented individuals in the industry. His coworkers, Tomio Kimura and Keisuke Suzuki, have contributed to his projects and research, fostering a collaborative environment that enhances creativity and innovation in their work.

Conclusion

Akira Nakao's contributions to scientific innovations, especially in developing compounds with enriching pharmacological properties, showcase his talent and dedication as an inventor. With a growing list of patents and collaborations, Nakao continues to advance the field, leaving a lasting impact on modern pharmaceuticals.

Profile summary based on public USPTO records.